Key result
SARS-CoV-2 infection was observed as an exposure preceding hypertriglyceridemia-induced acute pancreatitis in the reported patients.
Why the study?
COVID-19 affects multiple organ systems and can alter lipid profiles, with acute pancreatitis previously observed post-infection.
Case Report
Highlights a potential association between post-COVID-19 infection, hypertriglyceridemia, and acute pancreatitis.
Should not change practice; hypothesis-generating for a post-COVID pancreatitis link needing confirmation.
Coronavirus disease-2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus 2, is primarily a respiratory illness. The sequelae have been observed affecting multiple organ systems, adding to the morbidity and mortality of the disease. It has also been shown to have adverse effects on lipid profile in some case studies. Acute pancreatitis (AP) post-COVID-19 infection has been described previously. Hypertriglyceridemia (HTG) is a well-described cause of AP. Here, we report patients presenting with post-COVID-19 infection with HTG causing AP.
No takes yet. Share an insight, caveat, or question.
Vulpala et al. (2022) conducted a case report in Hypertriglyceridemia Associated Acute Pancreatitis Post SARS COV-2 Infection. SARS-CoV-2 infection was evaluated on Hypertriglyceridemia causing acute pancreatitis. SARS-CoV-2 infection was observed as an exposure preceding hypertriglyceridemia-induced acute pancreatitis in the reported patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: